On Friday, Shares of Qorvo Inc (NASDAQ:QRVO), added 3.80% and closed at $53.52 in the last trading session. The last trading range of the stock ranges between $52.59 and $54.58. ELECTRONICA 2016 — Qorvo® (QRVO), a leading provider of innovative RF solutions that connect the world, is assisting to advance smart home networking with a radio chip and software that significantly expand the ability of consumers to control their homes with spoken commands.
The GP712 radio chip supports multiple communication protocols in a single-chip design suited to connected-home applications. It was introduced earlier this year by GreenPeak Technologies – now Qorvo’s Low Power Wireless business – and is now in production.
When integrated into Virtual Personal Assistants (VPAs), the GP712 facilitates the VPA to respond to voice commands and communicate directly with millions of smart-home devices that use ZigBee® and Thread protocols. Formerly, a separate gateway was required to connect the VPA speaker with the ZigBee and Thread sentrollers.
Incyte Corporation (NASDAQ:INCY), dropped -0.19% and closed at $104.51 in the last trading session. The last trading range of the stock ranges between $102.29 and $105.73. The company’s Market capitalization is $19.65 Billion with the total Outstanding Shares of 188.93 million. Incyte Corporation (INCY) declares that more than 20 abstracts counting data from its ongoing clinical development program for Jakafi® (ruxolitinib) and its small molecule development programs targeting JAK1, LSD1 and PI3Kδ will be presented at the forthcoming American Society of Hematology (ASH) Annual Meeting 2016 in San Diego, California from December 3-6, 2016.
“We are happy to have an array of data highlighting the potential of our portfolio accepted for presentation at this year’s ASH meeting, counting the pooled overall survival analysis of five-year data from our COMFORT-I and COMFORT-II trials, which reinforces the long-term clinical profile of Jakafi; data from INCB39110, our selective JAK1 inhibitor, in acute graft-as compared to-host disease; and emerging data from our LSD1 and PI3Kδ inhibitor programs in other hematologic diseases,” said Steven Stein, M.D., Incyte’s Chief Medical Officer.
PPG Industries, Inc. (NYSE:PPG), dropped -1.14% and closed at $95.77 in the last trading session. The last trading range of the stock ranges between $95.49 and $92.27.The company stock’s 52-week range is $88.37 – $117.00. PPG (PPG) recently declared that it has purchased the remaining 50 percent ownership interest in PPG Univer S.p.A from its joint-venture partner, Univer Italiana S.r.l. Financial terms were not revealed.
PPG Univer manufactures architectural and liquid industrial coatings and, with its associates, employs about 150 people. It operates a network of 12 retail stores in Italy and maintains administrative offices and a production facility in the town of Cavallirio, Italy.
“This transaction is an important step in PPG’s effort to continue strengthening our presence in Europe, positioning us well for further growth in Italy,” said Jean-Marie Greindl, PPG senior vice president, global architectural coatings, and president, PPG Europe, Middle East and Africa (EMEA).